Nausheen Ahmed

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Nausheen Ahmed
Apr 11, 2025, 11:29 | Blog
Al-Ola A Abdallah: Main Speakers are ready for the 2025 National ICE-T Conference
Al-Ola A Abdallah, Associate Professor and Plasma Cell disorder program Director at University of Kansas Medical…
Mar 12, 2025, 09:58 | Science
Myeloma Paper of the Day, March 12th, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…
Mar 4, 2025, 04:35 | Blog
Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians
Razan Mohty, Assistant Professor at UAB Medicine, shared a paper she and her colleagues authored…
Jan 23, 2025, 02:32 | Blog
Muhammad Umair Mushtaq: Successful Use of a Midline Catheter for Leukapheresis in Immune Effector Cell Therapy
Muhammad Umair Mushtaq, Associate Professor of Medicine at the University of Kansas Medical Center, shared…
Dec 17, 2024, 01:10 | Science
Hung Trinh: Optimizing the post-CAR T monitoring period in recipients of Axi-cel, Tisa-cel, and Liso-cel by Nausheen Ahmed et al.
A recent paper by Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University…
Dec 8, 2024, 06:51 | Insight
Nico Gagelmann: Suggesting Bispecific Antibodies as Standard of Care for Relapse After CAR-T in Multiple Myeloma
Nico Gagelmann, Co-chair of EBMT’s Trainee Committee, shared a recent article on X: "Finally out…
Dec 7, 2024, 11:15 | Insight
First hit on Autologous Stem Cell Transplantation in Mantle cell lymphoma
Guilherme Perini, Hematologist at Hospital Israelita Albert Einstein in São Paulo, shared a post on…
Aug 24, 2024, 10:20 | Blog
Al-Ola Abdallah: Introduction to U.S. Myeloma Innovations Research Collaborative Group
Al-Ola Abdallah, Associate Professor Of Medicine at the University of Kansas Medical Center, shared a…
Aug 4, 2024, 12:40 | Blog
Nausheen Ahmed: My takeaways on monitoring post infusion, REMS, CRS, ICANS and infection
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Jul 30, 2024, 07:06 | Insight
Aaron Goodman: An informative paper about CD19 CART timing of complications
Aaron Goodman shared on X about a recent paper by Nausheen Ahmed et al. titled…
Jul 29, 2024, 06:08 | Blog
Nausheen Ahmed: KUICE-T kicks off with the reception at KU Cancer Center
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Jul 28, 2024, 15:37 | Insight
Timing of Toxicities and Mortality Following CAR T Therapy in Myeloma
Al-Ola A Abdallah, Plasma Cell Disorder Program Director, Division of HMCT/University of Kansas Medical Center,…
Jul 25, 2024, 20:13 | Insight
Optimizing the Post-CAR T Monitoring Period
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director at Division of HMCT/University…
Jun 24, 2024, 22:06 | Blog
Nausheen Ahmed: Approvals, toxicity and access updates on CART
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
May 22, 2024, 06:44 | Insight
Nausheen Ahmed: A deeper look at social determinants of health and CAR-T
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
May 21, 2024, 13:21 | Insight
Rahul Banerjee: Two-for-one with new MMsm articles in press in Transplantation and Cellular Therapy Journal
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
Apr 5, 2024, 15:18 | Career
Al-Ola Abdallah: A big congratulations to our esteemed colleagues, Drs. Male, Ahmed and Mushtaq for promotions
Al-Ola Abdallah, Plasma Cell Disorder Program Director of Division of HMCT/University of Kansas Medical Center,…
All: 17 Posts: 1 - 100
Special Coverage